Hunt For Viable Vectors Leads To Jobs For Gene Therapy Researchers

Therapy Researchers Sidebar: Summary Table of Vectors PROGRESS: Forrest Anthony says some FDA concerns have been allayed. Despite safety questions from federal agencies, the gene therapy industry is hotly pursuing new vectors. Since 1990, dozens of biotech and gene therapy companies have hired life scientists and launched research programs to find safe, effective carriers to shuttle therapeutic genes into the body. According to the Pasteur Institute, a nonprofit research organization in Pari

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Therapy Researchers

Sidebar: Summary Table of Vectors

According to the Pasteur Institute, a nonprofit research organization in Paris, 216 gene therapy protocols with human patients-treating diseases such as cystic fibrosis, cancer, and AIDS-are under way worldwide.

In the vast majority, therapeutic genes are packed into disarmed viruses, which shuttle the genetic payload into a cell's chromosomes.

These viral vectors require the expertise of virologists, biochemists, and molecular biologists, among others. Meanwhile, nonviral vectors-for example, synthetic molecules that tote therapeutic genes-call for biophysicists and analytical chemists.

Gene therapy researchers agree that finding-or creating-viable vectors is of utmost importance to patients and investigators. "There isn't much future to gene therapy without viable vectors," remarks Didier Trono, head of infectious diseases research at the Salk Institute for Biological Studies in La Jolla, Calif. "This is where work needs to be done."

Four types of vectors share the gene therapy spotlight: retroviruses, such as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Kathryn Brown

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio